121 related articles for article (PubMed ID: 8504793)
1. Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat.
Yan QS; Jobe PC; Dailey JW
Epilepsy Res; 1993 Mar; 14(3):229-36. PubMed ID: 8504793
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis.
Yan QS; Jobe PC; Dailey JW
Brain Res; 1993 Apr; 610(1):24-31. PubMed ID: 8518928
[TBL] [Abstract][Full Text] [Related]
3. Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): an in vitro study on the locus coeruleus.
Clough RW; Peterson BR; Steenbergen JL; Jobe PC; Eells JB; Browning RA; Mishra PK
Epilepsy Res; 1998 Jan; 29(2):135-46. PubMed ID: 9477146
[TBL] [Abstract][Full Text] [Related]
4. Noradrenergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats.
Dailey JW; Mishra PK; Ko KH; Penny JE; Jobe PC
Epilepsia; 1991; 32(2):168-73. PubMed ID: 2004621
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study.
Yan QS; Dailey JW; Steenbergen JL; Jobe PC
Brain Res; 1998 Jan; 780(2):199-209. PubMed ID: 9507130
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s).
Mishra PK; Kahle EH; Bettendorf AF; Dailey JW; Jobe PC
Life Sci; 1993; 52(17):1435-41. PubMed ID: 8464344
[TBL] [Abstract][Full Text] [Related]
7. Alterations in mRNA expression of systems that regulate neurotransmitter synaptic content in seizure-naive genetically epilepsy-prone rat (GEPR): transporter proteins and rate-limiting synthesizing enzymes for norepinephrine, dopamine and serotonin.
Szot P; Reigel CE; White SS; Veith RC
Brain Res Mol Brain Res; 1996 Dec; 43(1-2):233-45. PubMed ID: 9037538
[TBL] [Abstract][Full Text] [Related]
8. Diminished potassium-stimulated GABA release in vivo in genetically epilepsy-prone rats.
Lasley SM; Yan QS
Neurosci Lett; 1994 Jul; 175(1-2):145-8. PubMed ID: 7970197
[TBL] [Abstract][Full Text] [Related]
9. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
Yan QS; Jobe PC; Dailey JW
Eur J Pharmacol; 1994 Jan; 252(1):105-12. PubMed ID: 8149989
[TBL] [Abstract][Full Text] [Related]
10. Indices of noradrenergic function in the central nervous system of seizure-naive genetically epilepsy-prone rats.
Dailey JW; Jobe PC
Epilepsia; 1986; 27(6):665-70. PubMed ID: 2877867
[TBL] [Abstract][Full Text] [Related]
11. A microdialysis study of amino acid concentrations in the extracellular fluid of the substantia nigra of freely behaving GEPR-9s: relationship to seizure predisposition.
Doretto MC; Burger RL; Mishra PK; Garcia-Cairasco N; Dailey JW; Jobe PC
Epilepsy Res; 1994 Feb; 17(2):157-65. PubMed ID: 8194511
[TBL] [Abstract][Full Text] [Related]
12. Brain norepinephrine and convulsions in the genetically epilepsy-prone rat: sex-dependent responses to Ro 4-1284 treatment.
Mishra PK; Dailey JW; Reigel CE; Jobe PC
Life Sci; 1988; 42(11):1131-7. PubMed ID: 3347143
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats.
Dailey JW; Mishra PK; Ko KH; Penny JE; Jobe PC
Life Sci; 1992; 50(4):319-26. PubMed ID: 1732702
[TBL] [Abstract][Full Text] [Related]
14. Noradrenergic abnormalities in the genetically epilepsy-prone rat.
Jobe PC; Mishra PK; Browning RA; Wang C; Adams-Curtis LE; Ko KH; Dailey JW
Brain Res Bull; 1994; 35(5-6):493-504. PubMed ID: 7859107
[TBL] [Abstract][Full Text] [Related]
15. Effect of norepinephrine release on adrenoceptors in severe seizure genetically epilepsy-prone rats.
Seo DO; Shin CY; Ryu JR; Cheong JH; Choi CR; Dailey JW; Reith ME; Jobe PC; Ko KH
Eur J Pharmacol; 2000 May; 396(2-3):53-8. PubMed ID: 10822056
[TBL] [Abstract][Full Text] [Related]
16. Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy-prone rat.
Browning RA; Wade DR; Marcinczyk M; Long GL; Jobe PC
J Pharmacol Exp Ther; 1989 Apr; 249(1):229-35. PubMed ID: 2709332
[TBL] [Abstract][Full Text] [Related]
17. Alterations in spleen norepinephrine and lymphocyte [3H]dihydroalprenolol binding site number in genetically epilepsy-prone rats.
Carr JA; Ortiz KA; Paxton LL; Saland LC; Savage DD
Brain Behav Immun; 1993 Jun; 7(2):113-20. PubMed ID: 8394163
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities in norepinephrine turnover rate in the central nervous system of the genetically epilepsy-prone rat.
Jobe PC; Ko KH; Dailey JW
Brain Res; 1984 Jan; 290(2):357-60. PubMed ID: 6692149
[TBL] [Abstract][Full Text] [Related]
19. Roles of neurotransmitter amino acids in seizure severity and experience in the genetically epilepsy-prone rat.
Lasley SM
Brain Res; 1991 Sep; 560(1-2):63-70. PubMed ID: 1684733
[TBL] [Abstract][Full Text] [Related]
20. Noradrenergic and serotonergic determinants of seizure susceptibility and severity in genetically epilepsy-prone rats.
Jobe PC; Dailey JW; Reigel CE
Life Sci; 1986 Sep; 39(9):775-82. PubMed ID: 3747729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
